Published on 2/5/2024 in the Prospect News Structured Products Daily.
New Issue: RBC prices $750,000 barrier enhanced return notes linked to Eli Lilly
By Kiku Steinfeld
Chicago, Feb. 5 – Royal Bank of Canada priced $750,000 of 0% barrier enhanced return notes due Dec. 19, 2024 linked to the stock of Eli Lilly and Co., according to a 424B2 filing with the Securities and Exchange Commission.
If the stock return is positive, the payout at maturity will be par plus twice the gain, capped at 128.05%.
Investors will receive par if the stock declines by 20% or less and will lose 1% for every 1% that the stock declines from initial level.
RBC Capital Markets, LLC is the agent.
Issuer: | Royal Bank of Canada
|
Issue: | Barrier enhanced return notes
|
Underlying stock: | Eli Lilly and Co.
|
Amount: | $750,000
|
Maturity: | Dec. 19, 2024
|
Coupon: | 0%
|
Price: | Par
|
Payout at maturity: | Par plus twice any gain, capped at 128.05%; par if stock declines by 20% or less; otherwise, 1% loss for every 1% that the stock declines from initial level
|
Initial levels: | $447.71
|
Barrier levels: | $358.17; 80% of initial levels
|
Pricing date: | June 20, 2023
|
Settlement date: | June 23, 2023
|
Agent: | RBC Capital Markets, LLC
|
Fees: | 2.25%
|
Cusip: | 78016NJA6
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.